BCAL Diagnostics (ASX:BDX) Accounts Payable & Accrued Expense : A$0.77 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Accounts Payable & Accrued Expense?

BCAL Diagnostics's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$0.34 Mil) to Jun. 2023 (A$2.02 Mil) but then declined from Jun. 2023 (A$2.02 Mil) to Dec. 2023 (A$0.77 Mil).

BCAL Diagnostics's annual accounts payable & accrued expense increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.91 Mil) and increased from Jun. 2022 (A$0.91 Mil) to Jun. 2023 (A$2.02 Mil).

BCAL Diagnostics Accounts Payable & Accrued Expense Historical Data

The historical data trend for BCAL Diagnostics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Accounts Payable & Accrued Expense Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Accounts Payable & Accrued Expense

0.91

2.02

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			0.30	0.91	0.34	2.02	0.77

BCAL Diagnostics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.